Testing of Novel Dengue Virus 2 Vaccines in African Green Monkeys: Safety, Immunogenicity, and Efficacy
Authors:
- Katherine M. SmithKSKatherine M. Smith
- Kavita NandaKNKavita Nanda
- Carla J. SpearsCSCarla J. Spears
- Amanda PiperAPAmanda Piper
- Mariana RibeiroMRMariana Ribeiro
- Michelle QuilesMQMichelle Quiles
- Caitlin M. BriggsCBCaitlin M. Briggs
- Gwynneth S. ThomasGTGwynneth S. Thomas
- Malcolm E. ThomasMTMalcolm E. Thomas
- Dennis T. BrownDBDennis T. Brown
- Raquel HernandezRHRaquel Hernandez
- Victoria McCarlVMVictoria McCarl
Open Access
- 3 October 2012
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 87 (4) , 743-753
Abstract
The immunogenicity and safety of three novel host-range vaccines containing deletions in the transmembrane domain of dengue virus serotype 2 (DV2) E glycoprotein were evaluated in African green monkeys. The shorter transmembrane domains are capable of functionally spanning an insect but not a mammalian cell membrane, resulting in production of viral mutants that have reduced infectivity in mammalian hosts but efficient growth in insect cells. Groups of four monkeys received one dose each of test vaccine candidate with no booster immunization. After immunization, levels of viremia produced by each vaccine were determined by infectious center assay. Vaccine recipient immune response to wild-type DV2 challenge was measured on Day 57 by enzyme-linked immunosorbent assay and plaque reduction neutralization test. Two vaccines, DV2ΔGVII and DV2G460P, generated neutralizing antibody in the range of 700–900 50% plaque reduction neutralization test units. All three vaccine strains decreased the length of viremia by at least two days. No safety concerns were identified.Keywords
This publication has 59 references indexed in Scilit:
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virionsProceedings of the National Academy of Sciences, 2012
- Structural mutants of dengue virus 2 transmembrane domains exhibit host-range phenotypeVirology Journal, 2011
- Dengue Virus Pathogenesis: an Integrated ViewClinical Microbiology Reviews, 2009
- Growth and Maintenance of Vero Cell LinesCurrent Protocols in Microbiology, 2008
- Sindbis Virus Conformational Changes Induced by a Neutralizing Anti-E1 Monoclonal AntibodyJournal of Virology, 2008
- Primary and Secondary Infections ofMacaca fascicularisMonkeys with Asian and American Genotypes of Dengue Virus 2Clinical and Vaccine Immunology, 2008
- Anamnestic antibody response after viral challenge in monkeys immunized with dengue 2 recombinant fusion proteinsArchives of Virology, 2008
- Neutralization of animal virus infectivity by antibodyArchives of Virology, 2007
- Models of dengue virus infectionDrug Discovery Today: Disease Models, 2006
- Deletions in the Transmembrane Domain of a Sindbis Virus Glycoprotein Alter Virus Infectivity, Stability, and Host RangeJournal of Virology, 2003